PDB46 EVALUATING THE LONG-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA

DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK

Diabetes Therapy ◽

10.1007/s13300-018-0430-4 ◽

2018 ◽

Vol 9 (3) ◽

pp. 1217-1232 ◽

Cited By ~ 8

Author(s):

Richard F. Pollock ◽

◽

William J. Valentine ◽

Steven P. Marso ◽

Jens Gundgaard ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Cost Utility ◽

Insulin Degludec ◽

Short Term ◽

The Uk ◽

Basal Bolus

Download Full-text

Insulin degludec improves long‐term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal‐bolus insulin therapy

Diabetes Obesity and Metabolism ◽

10.1111/dom.12411 ◽

2014 ◽

Vol 17 (2) ◽

pp. 202-206 ◽

Cited By ~ 15

Author(s):

P. Hollander ◽

A. B. King ◽

S. Del Prato ◽

S. Sreenan ◽

M. K. Balci ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Insulin Therapy ◽

Insulin Degludec ◽

Bolus Insulin ◽

Basal Bolus

Download Full-text

PDB45 EVALUATING THE SHORT-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA

Value in Health ◽

10.1016/j.jval.2019.04.595 ◽

2019 ◽

Vol 22 ◽

pp. S147-S148

Author(s):

S. Han ◽

L.W. Shi ◽

H.K. SUN ◽

P.X. Dong ◽

L.Y. Zheng

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Cost Utility ◽

Insulin Degludec ◽

Short Term ◽

Basal Bolus

Download Full-text

Clinical Research of Insulin Glargine U300 basal‐bolus therapy and Insulin Degludec/Aspart Co‐Formulation in Type 2 Diabetes Mellitus: A Real World Experience (CRIGDA Study)

International Journal of Clinical Practice ◽

10.1111/ijcp.14377 ◽

2021 ◽

Author(s):

Savas Volkan Kisioglu ◽

Ahmet Suat Demir ◽

Damla Tufekci ◽

Yasemin Emur Gunay ◽

Hulya Coskun ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Clinical Research ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec ◽

Basal Bolus

Download Full-text

PDB79 - COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CROATIA

Value in Health ◽

10.1016/j.jval.2018.09.784 ◽

2018 ◽

Vol 21 ◽

pp. S131-S132

Author(s):

M. Bogdanovic ◽

M. Fournier ◽

D. Vitezic

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Cost Utility ◽

Cost Utility Analysis ◽

Insulin Degludec ◽

Utility Analysis

Download Full-text

Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cpp45203 ◽

2007 ◽

Vol 45 (04) ◽

pp. 203-221 ◽

Cited By ~ 18

Author(s):

M. Brändle ◽

M. Azoulay ◽

R.-A. Greiner

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Cost Utility ◽

Nph Insulin

Download Full-text

The management of type 2 diabetes with fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus basal-bolus therapy (insulin glargine U100 plus insulin aspart): A short-term cost-effectiveness analysis in the UK setting

Diabetes Obesity and Metabolism ◽

10.1111/dom.13375 ◽

2018 ◽

Vol 20 (10) ◽

pp. 2371-2378 ◽

Cited By ~ 9

Author(s):

Russell Drummond ◽

Samuel Malkin ◽

Michelle Du Preez ◽

Xin Ying Lee ◽

Barnaby Hunt

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Fixed Ratio ◽

Insulin Degludec ◽

Short Term ◽

Effectiveness Analysis ◽

The Uk ◽

Basal Bolus

Download Full-text

Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) In Patients With Type 2 Diabetes Mellitus In Slovenia

Value in Health ◽

10.1016/j.jval.2017.08.466 ◽

2017 ◽

Vol 20 (9) ◽

pp. A481

Author(s):

M Bogdanovic ◽

S Rados Krnel ◽

M Fournier

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Cost Utility ◽

Insulin Degludec ◽

Utility Evaluation

Download Full-text

Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) IN Patients With Type 2 Diabetes Mellitus In Serbia

Value in Health ◽

10.1016/j.jval.2017.08.467 ◽

2017 ◽

Vol 20 (9) ◽

pp. A481

Author(s):

J Mihajlović ◽

M Bogdanovic ◽

M Fournier

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Cost Utility ◽

Insulin Degludec ◽

Utility Evaluation

Download Full-text

Long-Term Cost Utility Analysis Of Ideglira Versus Basal-Bolus Insulin Intensification Therapies In Patients With Type 2 Diabetes Inadequately Controlled On Basal Insulin In Spain

Value in Health ◽

10.1016/j.jval.2016.03.1712 ◽

2016 ◽

Vol 19 (3) ◽

pp. A99

Author(s):

M Prades ◽

L Lizan ◽

B Hunt ◽

A Ramirez de Arellano

Keyword(s):

Type 2 Diabetes ◽

Basal Insulin ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Insulin Intensification ◽

Bolus Insulin ◽

Basal Bolus

Download Full-text